These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapeutic approaches to gastroesophageal junction adenocarcinomas. Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026 [TBL] [Abstract][Full Text] [Related]
7. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction. Pedrazzani C; de Manzoni G; Marrelli D; Roviello F J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616 [No Abstract] [Full Text] [Related]
8. [Role of postoperative chemoradiotherapy in the therapeutic management of adenocarcinomas of the stomach and oesogastric junction]. Ben Salah H; Bahri M; Dhouib F; Daoud J Cancer Radiother; 2016 Dec; 20(8):830-832. PubMed ID: 27793531 [TBL] [Abstract][Full Text] [Related]
9. [Long-term survival after perioperative chemotherapy of cancer of the gastroesophageal junction and the stomach-ECF vs. FLOT]. Schröder W; Bruns CJ Chirurg; 2020 Feb; 91(2):166. PubMed ID: 31993693 [No Abstract] [Full Text] [Related]
10. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K; Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671 [TBL] [Abstract][Full Text] [Related]
12. [Multimodal therapy for gastric or gastroesophageal junction adenocarcinoma -ECF vs. FLOT]. Schröder W; Bruns CJ Chirurg; 2017 Jun; 88(6):540. PubMed ID: 28477062 [No Abstract] [Full Text] [Related]
13. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management? Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690 [TBL] [Abstract][Full Text] [Related]
14. The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. Lutz MP; Zalcberg JR; Ducreux M; Adenis A; Allum W; Aust D; Carneiro F; Grabsch HI; Laurent-Puig P; Lordick F; Möhler M; Mönig S; Obermannova R; Piessen G; Riddell A; Röcken C; Roviello F; Schneider PM; Seewald S; Smyth E; van Cutsem E; Verheij M; Wagner AD; Otto F Eur J Cancer; 2019 May; 112():1-8. PubMed ID: 30878666 [TBL] [Abstract][Full Text] [Related]
15. [FLOT becomes standard neoadjuvant chemotherapy for adenocarcinoma of the esophagogastric junction and stomach]. Treese C; Harloff H; Daum S Z Gastroenterol; 2017 Sep; 55(9):881-882. PubMed ID: 29186642 [No Abstract] [Full Text] [Related]
16. Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions. Saba NF Oncology (Williston Park); 2014 Jun; 28(6):520-1. PubMed ID: 25134327 [No Abstract] [Full Text] [Related]
17. Curative management of adenocarcinoma of the oesophagus and oesogastric junction--current recommendations of the Belgian Working Group. Van Laethem JL; Baert F; Buset M; de Hemptine B; De Ronde T; Honoré P; Lerut T; Scaillet P; Van Cutsem E; Acta Gastroenterol Belg; 2000; 63(3):304-6. PubMed ID: 11189997 [No Abstract] [Full Text] [Related]
18. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study. Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792 [TBL] [Abstract][Full Text] [Related]
19. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS]. Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543 [TBL] [Abstract][Full Text] [Related]
20. Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma. Tepper JE; O'Neil B J Clin Oncol; 2009 Feb; 27(6):836-7. PubMed ID: 19139425 [No Abstract] [Full Text] [Related] [Next] [New Search]